| 000 | 01799 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513234206.0 | ||
| 264 | 0 | _c20010719 | |
| 008 | 200107s 0 0 eng d | ||
| 022 | _a0884-0431 | ||
| 024 | 7 |
_a10.1359/jbmr.2001.16.3.556 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWilkinson, J M | |
| 245 | 0 | 0 |
_aEffect of pamidronate in preventing local bone loss after total hip arthroplasty: a randomized, double-blind, controlled trial. _h[electronic resource] |
| 260 |
_bJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research _cMar 2001 |
||
| 300 |
_a556-64 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAlkaline Phosphatase _xblood |
| 650 | 0 | 4 |
_aAmino Acids _xurine |
| 650 | 0 | 4 | _aArthroplasty, Replacement, Hip |
| 650 | 0 | 4 |
_aBiomarkers _xanalysis |
| 650 | 0 | 4 | _aBone Density |
| 650 | 0 | 4 | _aBone Resorption |
| 650 | 0 | 4 |
_aCollagen _xmetabolism |
| 650 | 0 | 4 |
_aDiphosphonates _xadverse effects |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHip _xphysiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOsteoporosis _xprevention & control |
| 650 | 0 | 4 | _aPamidronate |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aStockley, I | |
| 700 | 1 | _aPeel, N F | |
| 700 | 1 | _aHamer, A J | |
| 700 | 1 | _aElson, R A | |
| 700 | 1 | _aBarrington, N A | |
| 700 | 1 | _aEastell, R | |
| 773 | 0 |
_tJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research _gvol. 16 _gno. 3 _gp. 556-64 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1359/jbmr.2001.16.3.556 _zAvailable from publisher's website |
| 999 |
_c11213063 _d11213063 |
||